Literature DB >> 19474750

Trends in incidence of oesophageal and stomach cancer subtypes in Europe.

Jessie Steevens1, Anita A M Botterweck, Miranda J M Dirx, Piet A van den Brandt, Leo J Schouten.   

Abstract

OBJECTIVE: Time trend studies in the USA have shown that the incidences of adenocarcinomas of the oesophagus and gastric cardia have risen strongly since the 1970s, whereas the incidence of squamous cell carcinomas of the oesophagus has declined. Earlier, we found that the incidence of these adenocarcinomas also rose in some European countries until the early 1990s. The main goal of this study was to investigate more recent trends in the incidence of oesophageal and stomach cancer subtypes in the European countries.
METHODS: Eurocim cancer incidence data of 23 cancer registries from 13 European countries were used to investigate the incidence trends in oesophageal and stomach cancer subtypes during the 1983-1997 period. We calculated estimated annual percentage changes (EAPCs) in European age-standardized incidence rates and 95% confidence intervals.
RESULTS: The incidence of adenocarcinomas of the oesophagus and gastric cardia rose in most, but not all, registration areas (EAPCs were usually 1-7%), the strongest in the UK and Ireland. Oesophageal squamous cell carcinoma incidence rose mostly in Northern European and Slovakian men (EAPCs: 1-5%) and in women from all regions (EAPCs: 1-8%), but declined mostly in Southern and Western European men (EAPCs: -1 to -5%).
CONCLUSION: Our results are partly in line with earlier findings on adenocarcinomas of the oesophagus and gastric cardia. There was, however, substantial heterogeneity in trends of subtypes of these cancers within Europe. There may be different risk factors for these cancers, and the prevalence of these risk factors may differ among countries.

Entities:  

Mesh:

Year:  2010        PMID: 19474750     DOI: 10.1097/MEG.0b013e32832ca091

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  79 in total

1.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study.

Authors:  Kazumasa Fujitani; Isao Miyashiro; Shoki Mikata; Shigeyuki Tamura; Hiroshi Imamura; Johji Hara; Yukinori Kurokawa; Jyunya Fujita; Kazuhiro Nishikawa; Yutaka Kimura; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2012-08-16       Impact factor: 7.370

3.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Authors:  Shivaram Bhat; Helen G Coleman; Fouad Yousef; Brian T Johnston; Damian T McManus; Anna T Gavin; Liam J Murray
Journal:  J Natl Cancer Inst       Date:  2011-06-16       Impact factor: 13.506

Review 4.  Biologic therapy in esophageal and gastric malignancies: current therapies and future directions.

Authors:  Pamela Samson; A Craig Lockhart
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 5.  Changing Trends in Stomach Cancer Throughout the World.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham
Journal:  Curr Gastroenterol Rep       Date:  2017-08

6.  Revisiting the infracardiac bursa using multimodal methods: topographic anatomy for surgery of the esophagogastric junction.

Authors:  Tatsuro Nakamura; Hisashi Shinohara; Tomoaki Okada; Shigeo Hisamori; Shigeru Tsunoda; Kazutaka Obama; Yasunori Kurahashi; Akihiro Takai; Tetsuya Shimokawa; Seiji Matsuda; Haruyuki Makishima; Tetsuya Takakuwa; Shigehito Yamada; Yoshiharu Sakai
Journal:  J Anat       Date:  2019-04-12       Impact factor: 2.610

7.  Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis.

Authors:  Nan Li; Jessica Leigh Petrick; Susan Elizabeth Steck; Patrick Terrence Bradshaw; Kathleen Michele McClain; Nicole Michelle Niehoff; Lawrence Stuart Engel; Nicholas James Shaheen; Douglas Allen Corley; Thomas Leonard Vaughan; Marilie Denise Gammon
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

8.  Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.

Authors:  Mitsuro Kanda; Hisaharu Oya; Shuji Nomoto; Hideki Takami; Dai Shimizu; Ryoji Hashimoto; Satoshi Sueoka; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

9.  Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma.

Authors:  Ashraf Fakhrjou; Seid Mahdi Niroumand-Oscoei; Mohamad Hosein Somi; Morteza Ghojazadeh; Shahnaz Naghashi; Shabnam Samankan
Journal:  J Gastrointest Cancer       Date:  2014-03

10.  Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study.

Authors:  Nobuhiro Takiguchi; Masazumi Takahashi; Masami Ikeda; Satoshi Inagawa; Shugo Ueda; Takayuki Nobuoka; Manabu Ota; Yoshiaki Iwasaki; Nobuyuki Uchida; Yasuhiro Kodera; Koji Nakada
Journal:  Gastric Cancer       Date:  2014-05-07       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.